Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)
This is an open label feasibility pilot study of commercially available physical activity monitoring devices in patients receiving systemic therapy at the Harold Simmons Cancer Center, UT Southwestern Medical Center.
Checked against the public recordLast updated May 11, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Texas Southwestern Medical Center
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Signed informed consent * Age 18 or above * Receiving or planning to receive outpatient therapy for any cancer * Baseline ECOG status 0-2; * Speak and understand English as all Psychological assessment tools included in this study have not been validated in Spanish; * Access to smartphone device compatible to sync with PAM Device Exclusion Criteria: * Recent injury which may result in impaired mobility; * Major surgery within 4 weeks or till recovery to baseline functioning (per patient) whichever is shorter; * Inability to comply with study requirement; * Medical, psychiatric condition which in the investigators opinion will affect the successful completion of study; * Current use of a wearable PAM device as defined by use of PAM device in the last 6 months
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- UT Southwestern Medical CenterDallas, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 11, 2018. Always confirm current availability with the study team.